Close

cannabinoids

CBD: Cannabidiol Breaks Out of the Legal Dispensary Channel

The latest Cannabis Intelligence Briefing from Arcview Market Research and BDS Analytics: CBD: Cannabidiol Escapes the Dispensary details CBD’s move from legal cannabis dispensaries to the general retail market. At present, the bulk (65%) of the $1.9 billion in annual spending on CBD products in the U.S. takes place through licensed […]

Read More

Pets, Pain and CBD: The Many Applications of Cannabinoid Products Webinar Recap

CBD: it spans product categories, retail channels, regulatory landscapes – and even species. Last month’s webinar covered the current cannabinoid market as it relates to pain management as well as pet care, both within the dispensary channel (CBD from marijuana) and in the general retail market (hemp-derived CBD). While pain […]

Read More

Top 5 Data Insights: Labor Day Weekend Sales

Top 5 BDS Analytics

We’re in no rush to say goodbye to summer, but, as we head into Labor Day weekend, let’s review how the cannabis industry has fared during Labor Day weekends past and other key summer holiday periods: Labor Day weekend has been a historically big for sales in the dispensary channel. […]

Read More

BDS Analytics’ Top 5 Insights From Our Upcoming Pet & Pain Webinar

Top 5 BDS Analytics

Our August webinar, Pet, Pain, and CBD: The Many Applications of Cannabinoid Products is coming up this week. Here is some of what you can expect to learn – be sure to tune in on Thursday for the full story. Register here: http://bit.ly/2MRJQbU Six in 10 Cannabis consumers use Cannabis […]

Read More

Gummies Are as Popular as Ever

gummies cannabis

Cannabis Ingestibles cover a lot of ground, including everything from pills to slices of pie to bottles of THC-infused cold-brewed coffee. But one style of ingestible dominates the market: the gummy. During the first four months of 2019, 17 of the top 20 selling ingestible products in California, Colorado and […]

Read More

Subscribe to Our Newsletter